6 Iodo-δ-lactone: A derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 4, 2013, Pages 273-280

  Thomasz, Lisa ^a   Oglio, Romina ^a   Rossich, Luciano ^a   Villamar, Sonia ^a,b   Perona, Marina ^a   Salvarredi, Leonardo ^a   Dagrosa, Alejandra ^a   Pisarev, Mario A ^a,b   Juvenal, Guillermo J ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Arachidonic acid; Colon cancer; Iodolactone; Iodolipids; Thyroid

Indexed keywords

5 HYDROXY 6 IODO 8,11,14 EICOSATRIENOIC DELTA LACTONE; ARACHIDONIC ACID; ARACHIDONIC ACID DERIVATIVE; CASPASE 3; CYCLINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL BLEBBING; CELL SHRINKAGE; CELL STRAIN HT29; CELL STRUCTURE; CELL VIABILITY; CELLULAR PARAMETERS; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; KARYORRHEXIS; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYKNOSIS; TUMOR VOLUME; TUMOR XENOGRAFT;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CELL PROLIFERATION; HT29 CELLS; HUMANS;

MUS MUSCULUS;

EID: 84880044160     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.01.002     Document Type: Article

References (51)

1. Pisarev M.A., Gärtner R R. Autoregulatory action of iodine. Werner & Ingbar's the Thyroid a Fundamental and Clinical Text 2000, 85-90. 8/e. L.E. Braverman, R.D. Uitger (Eds.).
2. Panneels V., Juvenal G., Boeynaems J.M., Dumont J.E., Van Sande J. Iodide effects on the thyroid: biochemical, physiological, pharmacological and clinical effects of iodide on the thyroid. Comprehensive Handbook on Iodine: Nutritional, Endocrine and Pathological Aspects 2009, 303-314. Oxford Academic Press, Oxford. V.R. Preedy, G.N. Burrow, R. Watson (Eds.).
3. Boeynaems J.M., Hubbard W.C. Transformation of arachidonic acid into an iodolactone by the rat thyroid. J. Biol. Chem. 1980, 255:9001-9004.
4. Dugrillon A., Bechtner G., Uedelhoven W.M., Weber P.C., Gartner R. Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3',5'-monophosphate formation. Endocrinology 1990, 127:337-343.
5. Pereira A., Braekman J.C., Dumont J.E., Boeynaems J.M. Identification of a major iodolipid from the horse thyroid gland as 2-iodohexadecanal. J. Biol. Chem. 1990, 265:17018-17025.
6. Pisarev M.A., Bocanera L.V., Chester H.A., Kleiman de Pisarev D.L., Juvenal G.J., Pregliasco L.B., Krawiec L. Effect of iodoarachidonates on thyroid FRTL-5 cells growth. Horm. Metab. Res. 1992, 24:558-561.
7. Dugrillon A., Uedelhoven W.M., Pisarev M.A., Bechtner G., Gärtner R. Identification of delta-iodolactone in iodide treated human goiter and its inhibitory effect on proliferation of human thyroid follicles. Horm. Metab. Res 1994, 26:465-469.
8. Pisarev M.A., Chazenbalk G.D., Valsecchi R.M., Burton G., Krawiec L., Monteagudo E., Juvenal G.J., Boado R., Chester H.A. Thyroid autoregulation. Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by iodinated derivatives of arachidonic acid. J. Endocrinol. Invest. 1988, 11:669-674.
9. 2 availability. Horm. Metab. Res. 1988, 20:86-90.
10. Thomasz L., Oglio R., Dagrosa M.A., Krawiec L., Pisarev M.A., Juvenal G.J. 6 Iodo-delta-lactone reproduces many but not all the effects of iodide. Mol. Cell. Endocrinol. 2010, 323:161-166.
11. Shrivastava A., Tiwari M., Sinha R.A., Kumar A., Balapure A.K., Bajpai V.K., Sharma R., Mitra K., Tandon A., Godbole M.M. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving mitochondriamediated pathway. J. Biol. Chem. 2006, 281:19762-19771.
12. Arroyo-Helguera O., Anguiano B., Delgado G., Aceves C. Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line. Endocr. Relat. Cancer 2006, 13:1147-1158.
13. Gärtner R., Rank P., Ander B. The role of iodine and δ-iodolactone in growth and apoptosis of malignant thyroid epithelial cells and breast cancer cells. Hormones 2010, 9:60-66.
14. Rösner H., Torremante P., Möller W., Gärtner R. Antiproliferative/cytotoxic activity of molecular iodine and iodolactones in various human carcinoma cell lines. No interfering with EGF-signaling, but evidence for apoptosis. Exp. Clin. Endocrinol. Diabetes 2010, 118:410-419.
15. Aranda N., Sosa S., Delgado G., Aceves C., Anguiano B. Uptake and antitumoral effects of iodine and 6-iodolactone in differentiated and undifferentiated human prostate cancer cell lines. Prostate 2013, 73:31-41.
16. Gustafson-Svärd C., Lilja I., Hallbook O., Sjodahl R. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut 1996, 38:79-84.
17. Azumaya M., Kobayashi M., Ajioka Y., Honma T., Suzuki Y., Takeuchi M., Narisawa R., Asakura Size-dependent expression of cyclooxygenase-2 in sporadic colorectal adenomas relative to adenomas in patients with familial adenomatous polyposis. Pathol. Int. 2002, 52:272-276.
18. Dong M., Johnson M., Rezaie A., Ilsley J.N.M., Nakanishi M., Sanders M.M., Forouhar F., Levine J., Montrose D.C., Giardina C., Rosenberg D.W. Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis. Clin. Cancer Res. 2005, 11:2265-2271.
19. Soumaoro L.T., Iida S., Uetake H., Ishiguro M., Takagi Y., Higuchi T., Yasuno M., Enomoto M., Sugihara K. Expression of 5-lipoxygenase in human colorectal cancer. World J. Gastroenterol. 2006, 12:6355-6360.
20. Wasilewicz M.P., KoŁodziej B., BojuŁko T., Kaczmarczyk M., Sulzyc-Bielicka V., Bielicki D., Ciepiela K. Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis. Int. J. Colorectal Dis. 2010, 25:1079-1085.
21. Wasilewicz M.P., KoŁodziej B., BojuŁko T., Kaczmarczyk M., Sulzyc-Bielicka V., Bielicki D. Expression of cyclooxygenase-2 in colonic polyps. Pol. Arch. Med. Wewn. 2010, 120:313-320.
22. Alexanian A., Miller B., Roman R.J., Sorokin A. 20-HETE-producing enzymes are up-regulated in human cancers. Cancer Genomics Proteomics 2012, 9:163-169.
23. Chan T.A., Morin P.J., Vogelstein B., Kinzler K.W. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Nat. Acad. Sci. U.S.A. 1998, 95:681-686.
24. Cao Y., Terrece Pearman A., Zimmerman G.A., McIntyre T.M., Prescott S.M. Intracellular unesterified arachidonic acid signals apoptosis. Proc. Nat. Acad. Sci. U.S.A. 2000, 97:11280-11285.
25. Monjazeb A.M., High K.P., Koumenis C., Chilton F.H. Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73:463-474.
26. Chazenbalk G.D., Valsecchi R.M., Krawiec L., Burton G., Juvenal G.J., Monteagudo E., Chester H.A., Pisarev M.A. Thyroid autoregulation. Inhibitory effects of iodinated derivatives of arachidonic acid on iodine metabolism. Prostaglandins 1988, 36:163-172.
27. Dugrillon A., Gärtner R. Delta-iodolactones decrease epidermal growth factor-induced proliferation and inositol-1,4,5-trisphosphate generation in porcine thyroid follicles-a possible mechanism of growth inhibition by iodide. Eur. J. Endocrinol. 1995, 132:735-743.
28. 131I by surviving slices of rat mammary tissue. Endocrinology 1956, 58:51-56.
29. Langer R., Burzler C., Bechtner G., Gärtner R. Influence of iodide and iodolactones on thyroid apoptosis. Evidence that apoptosis induced by iodide is mediated by iodolactones in intact porcine thyroid follicles. Exp. Clin. Endocrinol. Diabetes 2003, 111:325-329.
30. Arroyo-Helguera O., Rojas E., Delgado G., Aceves C. Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects. Endocr. Relat. Cancer 2008, 15:1003-1011.
31. Thomasz L., Oglio R., Randi A.S., Fernandez M., Dagrosa M.A., Cabrini R.L., Juvenal G.J., Pisarev M.A. Biochemical changes during goiter induction by methylmercaptoimidazol and inhibition by delta-iodolactone in rat. Thyroid 2010, 20:1003-1013.
32. Bhattacharya S., Mathew G., Jayne D.G., Pelengaris S., Khan M. 15-lipoxygenase-1 in colorectal cancer: a review. Tumour Biol. 2009, 30:185-199.
33. Wang D D., Dubois R.N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010, 29:781-788.
34. Al-Salihi M.A., Terrece Pearman A., Doan T., Reichert E.C., Rosenberg D.W., Prescott S.M., Stafforini D.M., Topham M.K. Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression. Cancer Lett. 2009, 273:225-232.
35. Chell S., Kaidi A., Williams A.C., Paraskeva C. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. Biochim. Biophys. Acta 2006, 1766:104-119.
36. Din F.V., Theodoratou E., Farrington S.M., Tenesa A., Barnetson R.A., Cetnarskyj R., Stark L., Porteous M.E., Campbell H., Dunlop M.G. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 2010, 59:1670-1679.
37. Ruder E.H., Laiyemo A.O., Graubard B.I., Hollenbeck A.R., Schatzkin A., Cross A.J. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective Cohort. Am. J. Gastroenterol. 2011, 106:1340-1350.
38. Serini S., Piccioni E., Merendino N., Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis 2009, 14:135-152.
39. 2+)-evoked activation of p38alpha MAPK and JNK1. Toxicology 2009, 262:199-206.
40. Dymkowska D., Wojtczak L. Arachidonic acid-induced apoptosis in rat hepatoma AS-30D cells is mediated by reactive oxygen species. Acta Biochim. Pol. 2009, 56:711-715.
41. Rolland S.G., Conradt B. New role of the BCL2 family of proteins in the regulation of mitochondrial dynamics. Curr. Opin. Cell Biol. 2010, 22:852-858.
42. Tait S.W., Green D.R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 2010, 11:621-632.
43. Kitamura M., Ishikawa Y., Moreno-Manzano V., Xu Q., Konta T., Lucio-Cazana J., Furusu A., Nakayama K. Intervention by retinoic acid in oxidative stress-induced apoptosis. Nephrol. Dial. Transplant. 2002, 17(Suppl 9):84-87.
44. Bécuwe P., Bianchi A., Didelot C., Barberi-Heyob M., Dauça M. Arachidonic acid activates a functional AP-1 and an inactive NF-kappaB complex in human HepG2 hepatoma cells. Free Radical Biol. Med. 2003, 35:636-647.
45. 2-induced acetylcholinesterase expression during apoptosis. Cell. Mol. Life Sci. 2008, 65:1435-1445.
46. Monjazeb A.M., High K.P., Connoy A., Hart L.S., Koumenis C., Chilton F.H. Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis 2006, 27:1950-1960.
47. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Nat. Acad. Sci. U.S.A. 1997, 94:4318-4323.
48. Rosen E.D., Spiegelman B.M. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 2001, 276:37731-37734.
49. Nuñez Anita R.E., Arroyo-Helguera A.O., Cajero-Juárez M., López-Bojorquez L., Aceves C. Complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplasic effect of iodine in mammary cancer. Prostaglandins Other Lipid Mediat. 2009, 89:34-42.
50. Aceves C., García-Solís P., Arroyo-Helguera O., Vega-Riveroll L., Delgado G., Anguiano B. Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR). Mol. Cancer 2009, 33.
51. Pisarev M.A., Krawiec L., Juvenal G.J., Bocanera L.V., Pregliasco L.B., Sartorio G., Chester H.A. Studies on the goiter inhibiting action of iodolactones. Eur. J. Pharmacol. 1994, 258:33-37.